Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma
- PMID: 38461467
- DOI: 10.1007/s00535-024-02090-2
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma
Abstract
Background: The tumor microbiome has been characterized in several malignancies; however, no previous studies have investigated its role in intrahepatic cholangiocarcinoma (ICC). Hence, we explored the tumor microbiome and its association with prognosis in ICC.
Methods: One hundred and twenty-one ICC tumor samples and 89 adjacent normal tissues were profiled by 16S rRNA sequencing. Microbial differences between tumor and adjacent nontumoral liver tissues were assessed. Tumor microbial composition was then evaluated to detect its association with prognosis. Finally, a risk score calculated by the tumor microbiota was accessed by the least absolute shrinkage and selector operator method (Lasso) to predict prognosis of ICC.
Results: The tumor microbiome displayed a greater diversity than that in adjacent nontumoral liver tissues. Tumor samples were characterized by a higher abundance of Firmicutes, Actinobacteria, Bacteroidetes, and Acidobacteriota. Higher tumor microbial α diversity was associated with lymph node metastasis and predicted shortened overall survival (OS) and recurrence-free survival (RFS). A total of 11 bacteria were selected to generate the risk score by Lasso. This score showed potential in predicting OS, and was an independent risk factor for OS.
Conclusion: In conclusion, our study characterized the tumor microbiome and revealed its role in predicting prognosis in ICC.
Keywords: 16S rRNA sequencing; Intrahepatic cholangiocarcinoma; Prognosis; Tumor microbiome.
© 2024. Japanese Society of Gastroenterology.
References
-
- Iida N, Dzutsev A, Stewart CA, et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science (New York, NY). 2013;342:967–70. - DOI
Publication types
MeSH terms
Substances
Grants and funding
- 81972708/National Natural Science Foundation of China
- 81773069/National Natural Science Foundation of China
- 82072681/National Natural Science Foundation of China
- 82003082/National Natural Science Foundation of China
- 82173260/National Natural Science Foundation of China
- 81830102/National Natural Science Foundation of China
- 81772578/National Natural Science Foundation of China
- 2019YFC1315800/Key Technologies Research and Development Program
- 2019YFC1315802/Key Technologies Research and Development Program
- 2018YFA0109400/Key Technologies Research and Development Program
LinkOut - more resources
Full Text Sources
Medical